Summary: ASHP has compiled available evidence on antiviral agents, supporting agents, and related medications for their use in treating COVID-19. In this document, readers can find information on the results of studies, clinical experience, doses used, and references to additional sources.
Updates: On May 15, 2020, updates were posted to the following sections: Remdesivir, Corticosteroids (general), Methylprednisolone (DEPOMedrol®, SOLUMedrol®), Sarilumab (Kefzara®), Tocilizumab (Actemra®), and Nitazoxanide.
Organization: American Society of Health-System Pharmacists (ASHP)
Title: Assessment of Evidence for COVID-19-Related Treatments
Web Link: Read more here!